0001767398-23-000001.txt : 20230811
0001767398-23-000001.hdr.sgml : 20230811
20230811095041
ACCESSION NUMBER: 0001767398-23-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20230811
DATE AS OF CHANGE: 20230811
EFFECTIVENESS DATE: 20230811
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Melt Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001767398
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 611888986
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-489452
FILM NUMBER: 231161903
BUSINESS ADDRESS:
STREET 1: 6 CADILLAC DRIVE
STREET 2: SUITE 320
CITY: BRENTWOOD
STATE: TN
ZIP: 37027
BUSINESS PHONE: 8587044042
MAIL ADDRESS:
STREET 1: 6 CADILLAC DRIVE
STREET 2: SUITE 320
CITY: BRENTWOOD
STATE: TN
ZIP: 37027
D
1
primary_doc.xml
X0708
D
LIVE
0001767398
Melt Pharmaceuticals, Inc.
6 CADILLAC DRIVE
SUITE 320
BRENTWOOD
TN
TENNESSEE
37027
629-802-9555
DELAWARE
None
None
Corporation
true
2019
Larry
Dillaha
6 Cadillac Drive
Suite 320
Brentwood
TN
TENNESSEE
37027
Executive Officer
Brad
Osborne
6 Cadillac Drive
Suite 320
Brentwood
TN
TENNESSEE
37027
Executive Officer
Pharmaceuticals
Decline to Disclose
- 06b
false
2023-07-28
false
true
false
0
Newbridge Securities Corporation
None
None
None
1200 North Federal Highway
Suite 400
Boca Raton
FL
FLORIDA
33432
DE
DELAWARE
false
30000000
1808970
28191030
false
37
135672
0
0
true
false
Melt Pharmaceuticals, Inc.
/s/ Brad Osborne
Brad Osborne
Chief Financial Officer
2023-08-11